Document Type
Article
Publication Date
Winter 1-1-2025
Abstract
African American individuals experience disproportionately high cancer mortality compared to White individuals,1 partly due to reduced access to high-quality care, including at early stages of the care continuum (eg, screening).1 These structural barriers may be perceived as beyond individuals’ control and contribute to fatalistic beliefs about cancer, shaping attitudes toward screening. Cancer fatalism is a multidimensional construct that includes cancer mortality salience (associating cancer with death) and occurrence fatalism (perceiving cancer risk as uncontrollable).2,3 Evidence linking fatalism and screening is mixed,3-5 suggesting a need to analyze its distinct components separately.3 Therefore, we used a national dataset to assess how cancer mortality salience and occurrence fatalism are associated with cancer screening interest among African American individuals at a population level in the US.
Digital Commons @ LMU & LLS Citation
Reese MT, Williamson TJ. Fatalism and Interest in Cancer Screening Among African American Individuals. JAMA Netw Open. 2025;8(8):e2526612. doi:10.1001/jamanetworkopen.2025.26612
